tiprankstipranks
Advertisement
Advertisement
NexGel closes acquisition of products from Celularity
PremiumThe FlyNexGel closes acquisition of products from Celularity
1M ago
Celularity Closes NexGel Asset Sale, Refocuses on Cell Therapy
Premium
Company Announcements
Celularity Closes NexGel Asset Sale, Refocuses on Cell Therapy
1M ago
Celularity announces closing of transaction with NexGel
Premium
The Fly
Celularity announces closing of transaction with NexGel
1M ago
NexGel sign agreement to license, acquire portfolio of products from Celularity
PremiumThe FlyNexGel sign agreement to license, acquire portfolio of products from Celularity
3M ago
Celularity secures $35M strategic license deal
Premium
The Fly
Celularity secures $35M strategic license deal
3M ago
Celularity receives $12.2M from sale of New Jersey net operating losses
Premium
The Fly
Celularity receives $12.2M from sale of New Jersey net operating losses
4M ago
Celularity announces up to $12M of capital from Philip Barach
PremiumThe FlyCelularity announces up to $12M of capital from Philip Barach
6M ago
Celularity Receives FDA Warning Over Marketing Claims
Premium
Company Announcements
Celularity Receives FDA Warning Over Marketing Claims
6M ago
Celularity, DefEYE partner to advance regenerative therapies in eye care
Premium
The Fly
Celularity, DefEYE partner to advance regenerative therapies in eye care
7M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100